Fishawack Health, a UK-based global commercialisation partner for the modern life science era, announced on Tuesday that it has named Jonathan (Jon) Koch as its new chief executive officer.
In the new role, Koch is to lead Fishawack Health through its next stage of growth, which is focused on building and retaining talented teams and delivering a complete set of integrated services for customers across the life science industry.
Koch has spent his complete career in the healthcare sector, including around 12 years at Covance as group president of Clinical Development and Commercialisation services. He has served as senior vice president and CEO of Global Dental at Henry Schein.
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers